Rare surgery saves 42-year-old woman suffering from advanced abdominal cancer

A rare operation at the Department of Surgical Oncology, Fortis Mohali, saved the life of a 42-year-old woman suffering from pseudomyxoma peritoneal (PMP) cancer, an advanced stage in the spread of the disease. This case is significant because PMP cancer is extremely rare, with an incidence rate of about 1-2 per million per year.

The medical team led by Dr. Jitender Rohila, specialist in surgical oncology and robotic surgeon, performed CRS (cytoreductive surgery) and HIPEC (hyperthermic intraperitoneal chemotherapy) surgery on the patient. CRS HIPEC has established itself as the gold standard for the surgical treatment of PMP cancer. It is a combination of complex surgery and intra-abdominal chemotherapy to eliminate advanced abdominal tumors. Cytoreductive surgery (CRS) involves removal of all cancerous foci in the abdominal cavity, while HIPEC surgery involves administering heated chemotherapy to the abdomen in the operating room after ensuring complete CRS.

The patient had severe abdominal swelling, changes in bowel habits, and loss of appetite. She had undergone surgery three months ago at another hospital for suspected ovarian cancer (uterus, both ovaries and appendix) as diagnostic reports showed a mucous tumor originating in the appendix. But since she wasn’t getting better, last month she turned to Dr. Rohila, where medical exams and CT scan showed mucous ascites (gelatinous substance in the abdomen) and tumor deposits throughout the abdominal cavity, suggesting PMP cancer.

dr Rohila said: “It was a complex operation that involved bowel resection and removal of the tumor from the liver and intestines. Complete cytoreduction took about eight hours. After the tumor was removed, HIPEC was performed for 90 minutes. The patient had a smooth postoperative recovery and was discharged 10 days later. She has made a full recovery and is leading a normal life today.”

READ :  US Silicon Valley bank collapse worries Indian startups

To explain the CRS HIPEC process, Dr. Rohila: “CRS HIPEC is used to treat cancer that has spread to the peritoneum, originating from cancer of the appendix, large intestine (colon and rectum), stomach, ovaries, or cancer that develops from the peritoneum (pseudomyxoma). peritonei, malignant peritoneal mesothelioma and primary peritoneal carcinoma. CRS HIPEC is a major surgical procedure and requires trained surgeons, experienced anesthesia teams and intensive care unit intensive care teams, an experienced medical oncology team to manage chemotherapy-related complications, an expert radiology team and an oncopathology team for the correct diagnosis, including the type, stage and grade of the Cancer; an interventional radiology facility to manage postoperative complications and a rehabilitation team to ensure a smooth and early recovery.”

Follow the 2023 general election results live today as they unfold

How will the results be in the 3 Northeast states? Follow live here
Will the BJP break the halfway mark in Tripura? Get real-time updates
Without an alliance, who will form the government in Meghalaya? Live updates here
Is NDPP scheduled for a second term in Nagaland? Find out here